Elephas is developing a unique diagnostic device that measures how a patient’s own tumor cells respond to cancer therapies. We are harnessing the latest advances in cancer biology, multimodal microscopy, engineering, and artificial intelligence to revolutionize cancer treatment.   While the system is being designed to help determine the best cancer therapy for each patient, there will be significant potential applications of the platform for biopharma companies developing oncology drugs and for cancer researchers.